Venture Partner, Main Sequence Ventures
| Role | Organisation | Sources |
|---|---|---|
| Ramsay Health Care | @AuManufacturing, Startup Daily | |
| Deputy | @AuManufacturing, Startup Daily | |
| Calix | @AuManufacturing, Startup Daily | |
| Chair (former) | Cochlear | Startup Daily (19 Mar 2024), @AuManufacturing, Startup Daily (9 Nov 2023) |
| Director (former) | Westpac | Startup Daily |
| Director (former) | IAG | Startup Daily |
| Venture Partner (former) | Main Sequence Ventures | Startup Daily (19 Mar 2024), @AuManufacturing, Startup Daily (9 Nov 2023) |
Stories naming Alison Deans. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Briefs roundup: Main Sequence adds Alison Deans as venture partner; Starpharma hands the CEO role to Cheryl Maley; DroneShield lands a $2.2 million repeat order; Q-CTRL will deliver quantum training with QUIN.
Main Sequence, CSIRO's deep tech venture fund, adds Cochlear chair Alison Deans as a venture partner, extending her investment committee service since 2017; its third fund brought in $450 million in July.